39 results · 37ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Verigene Gram Positive Blood Culture (BC-GP) Nucleic Acid Test

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 14, 2024

Luminex VERIGENE BC-GP Utility Tray (5-Pack Carrier), Gram-Positive Blood Culture Nucleic Acid Test, REF 20-011-018, a component of the Luminex VERIGENE BC-GP Utility Kit, REF 20-012-018, containing 20 tests.

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·December 13, 2023

ARIES SARS-CoV-2 Assay

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 24, 2022

ARIES System and ARIES M1 System

FDA Enforcement
Class II ·Terminated·Luminex Corporation·May 24, 2017

VERIGENE Blood Culture Gram-Positive Nucleic Acid Kits (packaged as five-pack carriers) Product Usage: In vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria.

FDA Enforcement
Class II ·Terminated·Luminex Corporation·November 21, 2018

Verigene Gram Negative Blood Culture Nucleic Acid Test (BC-GN) Model Number: 20-006-021

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·July 14, 2021

Verigene Enteric Pathogens Nucleic Acid Test (EP) Model Number: 20-006-023

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·July 14, 2021

Verigene Gram Negative Blood Culture Nucleic Acid Test v2 (BC-GNv2) Model Number: 20-006-026

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·July 14, 2021

Verigene Clostridium difficile Nucleic Acid Test Kit (CDF) Model Number: 20-006-022

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·July 14, 2021

Verigene Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) Model Number: 20-006-018

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·July 14, 2021

Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) Model Number: 20-006-024

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·July 14, 2021

Verigene Enteric Pathogens Nucleic Acid Test (EP) for detecting and identification of pathogenic enteric bacteria, viruses, and genetic virulence markers from liquid or soft stool preserved in Cary-Blair medium, collected from individuals with signs and symptoms of gastrointestinal infection.

FDA Enforcement
Class II ·Terminated·Luminex Corporation·September 5, 2018

Vergene Amplification Tray - 700uL, BC-GP REF 20-011-018 The Verigene(R) Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) performed using the sample-to-result Verigene System is a qualitative, multiplexed in vitro diagnostic test for the simultaneous detection and identification of potentially pathogenic gram-positive bacteria which may cause bloodstream infection (BSI). BC-GP is performed directly on blood culture bottles identified as positive by a continuous monitoring blood culture system and which contain gram-positive bacteria.

FDA Enforcement
Class III ·Terminated·Luminex Corporation·February 20, 2019

Aries Bordetella Assay, REF 50-10037, UDI # 00840487101452

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 21, 2019

ARIES Extraction Kit; ARIES System; SYNCT , REF 50-10026, UDI # 00840487100073

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 21, 2019

ARIES C. difficile Assay , REF 50-10018, UDI # 00840487100059

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 21, 2019

ARIES Flu A/B & RSV Assay , REF 50-10020, UDI # 00840487100158

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 21, 2019

ARIES GBS Assay , REF 50-10021, UDI # 00840487100165

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 21, 2019

ARIES Group A Strep Assay , REF 50-10041, UDI # 00840487101469

FDA Enforcement
Class II ·Ongoing·Luminex Corporation·August 21, 2019

Luminex Aries M1 System Model: Aries M6V1 Aries Software v1.0 For In Vitro Diagnostic Use in clinical laboratories. Scanner Label/Labeling: JADAK JDK-2330 REV B 170512-017

FDA Enforcement
Class II ·Terminated·Luminex Corporation·August 28, 2019